Navigation Links
Flagship Biosciences Partners with a Leading IHC CLIA Laboratory for Companion Diagnostics Service
Date:7/6/2010

Partnership with Vitro Molecular in histology and image analysis IHC biomarker development offers a complete companion diagnostics development service

(PRWEB) July 6, 2010 -- Flagship Biosciences LLC, a provider of digital pathology services, announced it has expanded its partnership with Vitro Molecular in Miami, Florida, to provide validated IHC companion diagnostic development capabilities. Vitro Molecular is a physician-owned, anatomic pathology specialty laboratory founded by Hadi Yaziji M.D. in 2007. Vitro provides routine and specialty anatomic pathology services to a loyal physician clientele in Florida and other States. The laboratory is well known for its excellence in histopathology, particularly IHC and other molecular tests. “Our pharmaceutical customers require a scalable histology operation with high levels of excellence and experience in immunohistochemistry,” said David Young, cofounder and president of Flagship Biosciences. “Quantitative image analysis techniques are strongly dependent on reproducible procedures in histology, and Dr. Hadi Yaziji and his team at Vitro Molecular have established themselves as leaders in high quality IHC testing. Dr. Yaziji’s strength in immunohistochemistry techniques, as demonstrated in his leadership of the Annual International Retreats on Applied Immunohistochemistry and Molecular Pathology, will be helpful to Flagship as we look to improve the reproducibility of molecular tissue-based testing.”

“We recognize the importance of whole slide analysis and computer histology pattern recognition in improving immunohistochemistry techniques. We are delighted to partner with Flagship Biosciences in working to ensure that their novel image analysis techniques utilize the best and most reproducible and scalable immunohistochemistry services,” stated Dr. Hadi Yaziji, founder and president of Vitro Molecular.

Flagship Biosciences LLC is a pathologist-owned company focused on utilizing whole slide scanning for quantitative pathology in pharmaceutical and device applications. An recent example of Flagship’s capabilities in companion diagnostics development of multiple IHC markers is their pathologists' work in the development of an epithelial-mesenchymal transition diagnostic test.

# # #

Read the full story at http://www.prweb.com/releases/2010/07/prweb4222034.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Active Innovations, Inc. Releases Version 8 of its Flagship Document Management Software Platform, infoRouter
2. HR Pharmaceuticals, Inc. to Launch and Showcase Flagship Product Line at the National Teaching Institute & Critical Care Nurses Exposition
3. Digital Pathology Services Firm Flagship Biosciences Appoints New CEO
4. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year-End 2009 Financial Results
5. Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership
6. Martek Biosciences and the National Center for Creative Aging Introduce New Brain Health Awareness Campaign, "Beautiful Minds: Finding Your Lifelong Potential"
7. Martek Biosciences Chief Scientific Officer, Dr. Norman Salem, 2010 Recipient of Alex Leaf Distinguished Scientist Award
8. New Speakers Announced for the 2010 Personalized Medicine Partnerships Conference
9. BABYCENTER Partners In Promoting Safe And Healthy Pregnancies Through Text4baby
10. Memory Loss Supplement Manufacturer Partners With Nationally-Syndicated Radio Host John Tesh
11. Royal Caribbean International and LimoRes.com Announce Exclusive Partnership
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Flagship Biosciences Partners with a Leading IHC CLIA Laboratory for Companion Diagnostics Service 
(Date:9/26/2017)... ... 26, 2017 , ... Founded as an independent institute in 1968, The ... special education. In 2018, Glenholme will celebrate its first 50 years and set ... farm for Hackney show ponies, was generously donated by Jean White Van Sinderen to ...
(Date:9/26/2017)... , ... September 26, 2017 , ... ... are collaborating on strategic and tactical plans for Pittcon 2018. As of July ... as president along with his named vice president, Charles Gardner, (ChemImage Corporation) and ...
(Date:9/26/2017)... ... ... “Childhood Memories of a Virginia Wanderer”: an entertaining look inside the author’s ... youth. “Childhood Memories of a Virginia Wanderer” is the creation of published author, Dewey ... He received his BS from Idaho State University in Adult Education, as well as ...
(Date:9/26/2017)... ... September 26, 2017 , ... Time out for Daddy is ... boy's newfound understanding that even grownups make mistakes. “Time Out for Daddy” is the ... for her entire life and whose passion for children inspired her to write this ...
(Date:9/25/2017)... ... ... The Renal Support Network (RSN) is proud to announce the launch of our ... on RSN’s mission to empower people who have kidney disease to become knowledgeable about ... unique website is loaded with hundreds of exclusive personal stories. These posts are written ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... INDIANAPOLIS , Sept. 6, 2017 Eli ... today it will present new data for galcanezumab and ... Congress of the International Headache Society (IHC) taking place ... Lilly will highlight new, long-term data from ... two doses of galcanezumab (120 mg and 240 mg) ...
(Date:9/5/2017)... 18 months after its February 2016 launch, market access ... of three new senior people to its rapidly expanding ... and James Wright bring decades of specialist ... Tammy Wynne joins as Director, Value Communication, ... over ten years, experience in global market access consultancy ...
(Date:9/1/2017)... 2017  Bayer will present the latest research from across ... Oncology (ESMO) 2017 Congress, September 8-12 in Madrid, ... and clinical data on Bayer,s marketed portfolio and late-stage compounds ... "We value the opportunity ... research at ESMO," said Carsten Brunn , Head of ...
Breaking Medicine Technology: